School of Biological Sciences, University of Nebraska at Lincoln, Lincoln, Nebraska, United States of America.
PLoS One. 2010 Jul 22;5(7):e11690. doi: 10.1371/journal.pone.0011690.
The minor T-allele of rs780094 in the glucokinase regulator gene (GCKR) associates with a number of metabolic traits including higher triglyceride levels and improved glycemic regulation in study populations of mostly European ancestry. Using data from the Atherosclerosis Risk in Communities (ARIC) Study, we sought to replicate these findings, examine them in a large population-based sample of African American study participants, and to investigate independent associations with other metabolic traits in order to determine if variation in GKCR contributes to their observed clustering. In addition, we examined the association of rs780094 with incident diabetes, coronary heart disease (CHD), and stroke over up mean follow-up times of 8, 15, and 15 years, respectively.
Race-stratified analyses were conducted among 10,929 white and 3,960 black participants aged 45-64 at baseline assuming an additive genetic model and using linear and logistic regression and Cox proportional hazards models.
Previous findings replicated among white participants in multivariable adjusted models: the T-allele of rs780094 was associated with lower fasting glucose (p = 10(-7)) and insulin levels (p = 10(-6)), lower insulin resistance (HOMA-IR, p = 10(-9)), less prevalent diabetes (p = 10(-6)), and higher CRP (p = 10(-8)), 2-h postprandial glucose (OGTT, p = 10(-6)), and triglyceride levels (p = 10(-31)). Moreover, the T-allele was independently associated with higher HDL cholesterol levels (p = 0.022), metabolic syndrome prevalence (p = 0.043), and lower beta-cell function measured as HOMA-B (p = 0.011). Among black participants, the T-allele was associated only with higher triglyceride levels (p = 0.004) and lower insulin levels (p = 0.002) and HOMA-IR (p = 0.013). Prospectively, the T-allele was associated with reduced incidence of diabetes (p = 10(-4)) among white participants, but not with incidence of CHD or stroke.
Our findings indicate rs780094 has independent associations with multiple metabolic traits as well as incident diabetes, but not incident CHD or stroke. The magnitude of association between the SNP and most traits was of lower magnitude among African American compared to white participants.
葡萄糖激酶调节基因(GCKR)中的 rs780094 次要 T 等位基因与多种代谢特征相关,包括在大多数欧洲血统的研究人群中更高的甘油三酯水平和改善的血糖调节。利用社区动脉粥样硬化风险(ARIC)研究的数据,我们试图复制这些发现,在一个大型的基于人群的非裔美国参与者样本中进行研究,并研究与其他代谢特征的独立关联,以确定 GCKR 中的变异是否导致了观察到的聚类。此外,我们还检查了 rs780094 与随后发生的糖尿病、冠心病(CHD)和中风的关联,平均随访时间分别为 8、15 和 15 年。
根据加性遗传模型,在基线时年龄为 45-64 岁的 10929 名白人参与者和 3960 名黑人参与者中进行了种族分层分析,并使用线性和逻辑回归以及 Cox 比例风险模型。
在多变量调整模型中,白人参与者中复制了先前的发现:rs780094 的 T 等位基因与空腹血糖(p = 10(-7))和胰岛素水平(p = 10(-6))降低、胰岛素抵抗(HOMA-IR,p = 10(-9))降低、糖尿病患病率(p = 10(-6))降低、C 反应蛋白(CRP)水平(p = 10(-8))升高、2 小时餐后血糖(OGTT,p = 10(-6))和甘油三酯水平(p = 10(-31))降低有关。此外,T 等位基因与更高的高密度脂蛋白胆固醇水平(p = 0.022)、代谢综合征患病率(p = 0.043)和作为 HOMA-B 测量的较低β细胞功能(p = 0.011)独立相关。在黑人参与者中,T 等位基因仅与更高的甘油三酯水平(p = 0.004)和更低的胰岛素水平(p = 0.002)和 HOMA-IR(p = 0.013)相关。前瞻性研究表明,T 等位基因与白人参与者中糖尿病发病率降低(p = 10(-4))相关,但与 CHD 或中风发病率无关。
我们的研究结果表明,rs780094 与多种代谢特征以及糖尿病的发生具有独立关联,但与 CHD 或中风的发生无关。与白人参与者相比,SNP 与大多数特征之间的关联程度在非裔美国人中要低。